Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 18, 2023

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2027

Conditions

Head and Neck NeoplasmsMSI-H CancerMelanoma

Interventions

DRUG

Tiragolumab and atezolizumab

three weekly tiragolumab 1200 mg intravenous plus tiragolumab 600 mg intravenous.

Trial Locations (1)

RECRUITING

University Medical Center Groningen, Groningen

All Listed Sponsors

lead

University Medical Center Groningen

OTHER

NCT05483400 - Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors | Biotech Hunter | Biotech Hunter